9th Circ. Allows CTI Contract Dispute To Go Forward

A federal appeals court has found that Cell Therapeutics Inc.'s settlement of a qui tam suit should not preclude it from bringing suit seeking contractual indemnification from its reimbursement consultant for...

Already a subscriber? Click here to view full article